Retailers could be in for a jolly jump in holiday sales despite headwinds like the U.S.-China trade war and threat of another economic slowdown.Retailread more
After a series of setbacks on the road to an initial public offering, the parent company of real estate start-up WeWork is delaying the move, sources told CNBC Monday.Technologyread more
Apple isn't trying to blow our minds with groundbreaking new features on the iPhone 11, but is making lots of little improvements each year, this year focusing on cameras and...Technologyread more
Saudi Arabia's defense spending is the world's third-largest — behind the U.S. and China, says Gary Grappo, former U.S. ambassador to Oman.Energyread more
Chinese officials are expected to be in Washington this week to hold consultations with the U.S. ahead of high-level trade talks in October.World Economyread more
The ballot comes at a precarious time for the country's longest serving prime minister, with the right-wing incumbent facing formidable challenges.World Politicsread more
Iran will never hold talks with America, the country's Supreme Leader Ayatollah Ali Khamenei said on state television Tuesday morning.Politicsread more
Energy stocks are on fire Monday. Five experts weigh in on what this could mean.Trading Nationread more
President Donald Trump said Monday he's in no rush to respond to a coordinated attack that hit Saudi Arabia's oil industry over the weekend.Marketsread more
The price of oil could go sharply higher, depending on the duration of the disruption at Saudi oil facilities and whether there is a military response.Powering the Futureread more
Energy stocks, one of the worst-performing sectors this year, spiked Monday after an attack on Saudi Arabia's heart of oil production Saturday sent oil prices soaring.Marketsread more
A medication used to treat hypothyroidism has been voluntarily recalled due to quality concerns.
Westminster Pharmaceuticals, LLC has instructed wholesalers to stop distributing specific products labeled "Levothyroxine and Liothyronine (Thyroid Tablets, USP)," according to an August 9 release. Levothyroxine and Liothyronine are synthetic hormones contained in the thyroid tablets.
The voluntary national recall alert says there have been no "adverse events" associated with the recalled products. It says patients should continue taking the drugs.
More from USA Today:
Oatmeal, breakfast foods contain unsafe amounts of cancer-linked weed killer
Is this drug the most promising development on Alzheimer's in recent history?
FDA expands recall of heart drug for possible cancer-causing contamination
"Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product," the release says.
More than 4.5 percent of the U.S. population over the age of 12 suffers from an underactive thyroid or hypothyroidism, according to the National Library of Medicine's MedlinePlus.
The release instructs patients to speak with their physician before discontinuing use of the medicine.
The recall follows a June 22 warning letter from the Food & Drug Administration to a Chinese pharmaceutical company which manufactured active ingredients in the recalled drug. The letter cited a number of failures, including ones relating to "established standards of quality and purity."
The recall alert says issues cited in that warning letter "could represent the possibility of risk being introduced into the manufacturing process."
A full list of recalled products is available from the FDA.
Patients with questions or information about an issue relating to the recalled products can contact Westminster at: 888-354-9939.